Simultaneous ring voice-over-internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials

Cerebrovascular Diseases

Volumn 28, Issue 6, 2009, Pages 539-544

  Sanossian, Nerses ^a   Starkman, Sidney ^b   Liebeskind, David S ^b   Ali, Latisha K ^b   Restrepo, Lucas ^b   Hamilton, Scott ^c   Conwit, Robin ^d   Saver, Jeffrey L ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Clinical trial; Informed consent; Magnesium; Prehospital trials; Stroke

Indexed keywords

MAGNESIUM SULFATE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EMERGENCY CARE; FEMALE; HUMAN; INFORMED CONSENT; INTERNET; INTERNET PROTOCOL; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; MULTICENTER STUDY; PHYSICIAN; PRIORITY JOURNAL; RELIABILITY; SIMULTANEOUS RING VOICE OVER INTERNET PROTOCOL; STROKE;

AGED; CALCIUM CHANNEL BLOCKERS; CELLULAR PHONE; FEMALE; HUMANS; INFORMED CONSENT; INTERNET; LOS ANGELES; MAGNESIUM SULFATE; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); PHYSICIANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TIME FACTORS; UNITED STATES;

EID: 70350048541     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247596     Document Type: Article

References (14)

1. Saver JL, Kidwell C, Eckstein M, Ovbiagele B, Starkman S: Physician-investigator phone elicitation of consent in the field: a novel method to obtain explicit informed consent for prehospital clinical research. Prehosp Emerg Care 2006; 10: 182-185.
2. Barsan WG, Pancioli AM, Conwit RA: Executive summary of the National Institute of Neurological Disorders and Stroke conference on Emergency Neurologic Clinical Trials Network. Ann Emerg Med 2004; 44: 407-412.
3. Saver JL, Kidwell C, Eckstein M, Starkman S: Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FASTMAG) pilot trial. Stroke 2004; 35:e106-e108.
4. Ovbiagele B, Kidwell CS, Starkman S, Saver JL: Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr Treat Options Cardiovasc Med 2003; 5: 441-449.
5. Savitz SI, Fisher M: Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol 2007; 61: 396-402.
6. Biros MH: Research without consent: exception from and waiver of informed consent in resuscitation research. Sci Eng Ethics 2007; 13: 361-369.
7. Saver J, American Stroke Association: Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American Stroke Association. Acad Emerg Med 2007; 14:e57-e58.
8. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects Research. Washington, Department of Health, Education and Welfare, 1978.
9. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien P-Y, Cristofini P, Leizorovicz A, Touboul P, Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Investigators: Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003; 108: 2851-2856.
10. Rosenberg DG, Levin E, Lausell A, Brown A, Gardner J, Perez E, Veenendaal M, Ong YS, Gunn M: Feasibility and timing of prehospital administration of reteplase in patients with acute myocardial infarction. J Thromb Thrombolysis 2002; 13: 147-153.
11. Iwanowski P, Budaj A, Czlonkowska A, Wasek W, Kozlowska-Boszko B, Oledzka U, Maselbas W: Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes. Trials 2008; 9: 45.
12. Saver JL, Starkman S, Fox S, Saver R, Biller J: The impact upon clinical stroke trials of restricting informed consent. Stroke 1995; 26: 157.
13. Flaherty ML, Karlawish J, Khoury JC, Kleindorfer D, Woo D, Broderick JP: How important is surrogate consent for stroke research? Neurology 2008; 71: 1562-1563.
14. Ferguson KN, Kidwell CS, Starkman S, Saver JL: Hyperacute treatment initiation in neuroprotective agent stroke trials. J Stroke Cerebrovasc Dis 2004; 13: 109-112.